Provision of the Molecular Diagnostic European Quality Assurance programmes
Public Health England (PHE) awarded the contract for the provision of the Molecular Diagnostic European Quality Assurance (EQA) Programmes to Quality Control for Molecular Diagnostics (QCMD). PHE believes that QCMD are the sole UK provider for the required broad range of services including the challenging samples.
Buyer
Public Health England
Value
£100,000
Published
6 Mar 2017
Closes
23 Jan 2017
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Limited
Category
Services
Contract starts
6 Mar 2017
Contract ends
28 Feb 2018
CPV classifications
72225000
System quality assurance assessment and review services
Lots
Lot default Provision of the Molecular Diagnostic European Quality Assurance programmes
£100,000
Public Health England (PHE) awarded the contract for the provision of the Molecular Diagnostic European Quality Assurance (EQA) Programmes to Quality Control for Molecular Diagnostics (QCMD). PHE believes that QCMD are the sole UK provider for the required broad range of services including the challenging samples.
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
6 Mar 2017
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.